India's Cadila Sets Up Tokyo Office

September 2006 | Company Finance Alert

Cadila Healthcare, part of India's third-largest drug manufacturing group, Zydus Cadila, is to market its generics and active pharmaceutical ingredients (APIs) in Japan. The company has recruited a former senior official at Japanese drugmaker Eisai to head a new office in Tokyo. Cadila will join a number of its Indian peers in entering the underdeveloped Japanese generics sector, where BMI expects sales to grow at an annual rate of 20% over the next five

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.